Follow
Doctors without Boards declared that researchers intend to begin the clinical experiment of two Ebola therapies in December. Experts expect to get the results of the three experimental drugs till the end of February 2015.
The medical humanitarian group informed that the tests will be carried out on the patients of treatment center of Guinea. The Ebola outburst slammed Guinea really badly.
As per the reports of World Health Organization around 15,000 Ebola cases are diagnosed in Guinea, Sierra Leona and Liberia.
The studies will examine the therapies that are currently in use of Europe and USA for the cure of Ebola. These antiviral drugs are brincidofvir and favipiravir. The Chinmerix Inc of Durham developed brincidofovir in order to treat the infections DNA containing virus. It is considered as the modified version of an antiviral drug known as cidofovir. It averts the progression of several DNA viruses such as herpes viruses and poxviruses.
On the other hand, favipiravir is manufactured by Toyama Chemical Unit situated in Japan. It is a medicine which is utilized for the cure of influenza, West Nile Virus, Yellow fever Virus and foot and mouth disease. Currently, the dug is being sold under the name of Avigan.
Researchers will observe the number of patients that survived after the use of these medications. Moreover, experts notified that they are presently designing the appropriate method for this experiment.
Jason Leathers
Jason is a graduate of Biology and Chemistry, who wishes he had more time to spend travelling, immersing himself in new cultures and enjoying the outdoors. He is keen on digging for the latest news pertaining to pharmacology, medical stories and science related topics. From delving into these sources to creating compelling stories that are attractive for his readers, Jason enjoys every moment of it.
